Rezolute

Louisville, United States

Rezolute is a clinical-stage biopharma specializing in the development of drug therapies for patients with metabolic and orphan diseases.

$96.9M raised

Apr 2025

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Rezolute raised?

Rezolute has raised $96.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2025.

Who are Rezolute's investors?

Rezolute's investors include Great Point Partners, Blackstone Group, Biotechnology Value Fund, SLR Capital Partners, Ildong Pharmaceutical.

Where is Rezolute headquartered?

Rezolute is headquartered in Louisville, United States.

What does Rezolute do?

Rezolute is a clinical-stage biopharma specializing in the development of drug therapies for patients with metabolic and orphan diseases.

What stage is Rezolute at?

Rezolute is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 23, 2025.

MLA

"Rezolute — Funding & Investors." VCBacked, April 23, 2025, https://www.vcbacked.co/company/rezolute. Accessed July 2, 2026.

APA

VCBacked. (2025). Rezolute — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/rezolute

Wikipedia (cite web)

{{cite web |title=Rezolute — Funding & Investors |url=https://www.vcbacked.co/company/rezolute |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 23, 2025.